Centene (NYSE:CNC) Shares Acquired Rep. Tim Moore

Key Points

• Representative Tim Moore recently purchased between $15,001 and $50,000 in Centene Corporation (NYSE:CNC) stock on July 30th, 2025.
• Centene's stock has decreased by 2.7%, with a current trading price around $25.20, significantly lower than its fifty-two week high of $80.59.
• Analysts have downgraded Centene's price targets, with several firms reducing their estimates to a range between $28.00 and $31.00, indicating a shift in market sentiment.

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation NYSE: CNC. In a filing disclosed on August 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on July 30th.

Representative Tim Moore also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Harley-Davidson NYSE: HOG on 7/30/2025.
• Purchased $15,001 - $50,000 in shares of Verizon Communications NYSE: VZ on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Krispy Kreme NASDAQ: DNUT on 7/29/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/29/2025.
• Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/21/2025.
• Purchased $15,001 - $50,000 in shares of Centene NYSE: CNC on 7/18/2025.

Centene Trading Up 1.3%

NYSE CNC traded up $0.32 during mid-day trading on Friday, reaching $25.58. 11,416,944 shares of the stock were exchanged, compared to its average volume of 8,368,974. The stock has a market capitalization of $12.56 billion, a PE ratio of 6.33, a PEG ratio of 1.03 and a beta of 0.40. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $80.59. The business's fifty day simple moving average is $40.30 and its 200 day simple moving average is $53.31.

Centene (NYSE:CNC - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.39). Centene had a net margin of 1.15% and a return on equity of 9.57%. The business had revenue of $48.74 billion during the quarter, compared to analysts' expectations of $44.71 billion. During the same period in the prior year, the firm earned $2.42 EPS. Centene's revenue for the quarter was up 22.4% on a year-over-year basis. On average, research analysts anticipate that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Institutional Trading of Centene

A number of hedge funds and other institutional investors have recently modified their holdings of CNC. Pinney & Scofield Inc. purchased a new stake in Centene during the 4th quarter worth approximately $25,000. Ameriflex Group Inc. bought a new stake in shares of Centene in the fourth quarter worth $26,000. Quarry LP acquired a new stake in Centene in the first quarter valued at $26,000. Studio Investment Management LLC bought a new position in Centene during the 4th quarter valued at $32,000. Finally, Golden State Wealth Management LLC grew its holdings in Centene by 203.1% during the 1st quarter. Golden State Wealth Management LLC now owns 579 shares of the company's stock worth $35,000 after acquiring an additional 388 shares in the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Theodore R. Samuels II purchased 9,000 shares of the firm's stock in a transaction that occurred on Monday, July 28th. The stock was acquired at an average cost of $27.62 per share, for a total transaction of $248,580.00. Following the completion of the purchase, the director owned 32,000 shares of the company's stock, valued at approximately $883,840. This trade represents a 39.13% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.36% of the company's stock.

Wall Street Analysts Forecast Growth

CNC has been the subject of a number of recent analyst reports. Robert W. Baird lowered their target price on shares of Centene from $68.00 to $28.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Oppenheimer dropped their price objective on Centene from $51.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, July 28th. Guggenheim reissued a "neutral" rating on shares of Centene in a research report on Tuesday, April 29th. Wells Fargo & Company lowered Centene from an "overweight" rating to an "equal weight" rating and reduced their price objective for the company from $72.00 to $30.00 in a research note on Wednesday, July 23rd. Finally, JPMorgan Chase & Co. dropped their target price on shares of Centene from $48.00 to $30.00 and set a "neutral" rating for the company in a research report on Tuesday, July 29th. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $42.20.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.